x
Filter:
Filters applied
- ACMG Statements and Guidelines
- Research ArticleRemove Research Article filter
- prenatal diagnosisRemove prenatal diagnosis filter
- access to healthcareRemove access to healthcare filter
Publication Date
Please choose a date range between 2020 and 2020.
ACMG Statements and Guidelines
These online statements and guidelines are definitive and may be cited using the digital object identifier (DOI). These recommendations are designed primarily as an educational resource for medical geneticists and other healthcare providers to help them provide quality medical genetics services; they should not be considered inclusive of all proper procedures and tests or exclusive of other procedures and tests that are reasonably directed to obtaining the same results. Please refer to the leading disclaimer in each document for more information.
1 Results
- ACMG StatementOpen Archive
Access to reproductive options after prenatal diagnosis—patient access and physician responsibilities: an updated position statement of the American College of Medical Genetics and Genomics (ACMG)
Genetics in MedicineVol. 22Issue 1p3Published in issue: January, 2020- ACMG Board of Directors
Cited in Scopus: 3The American College of Medical Genetics and Genomics (ACMG) is concerned with the enactment of laws in some states that prevent or restrict access to termination of pregnancy after prenatal diagnosis of genetic disorders or congenital anomalies. The practice of medical genetics is predicated on the principle of providing patients with complete and accurate information on the condition that affects them, a member of their family, or an unborn fetus, and then discussing the management options that are available.
